A paradoxical role for IFN-γ in the immune properties of mesenchymal stem cells during viral challenge

被引:52
作者
Kang, HS
Habib, M
Chan, J
Abavana, C
Potian, JA
Ponzio, NM
Rameshwar, P
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA
关键词
D O I
10.1016/j.exphem.2005.03.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The functional "plasticity" and immune-suppressive effects of human bone marrow (BM)-derived mesenchymal stem cells (MSC) provide them with the potential to be used across allogeneic barriers. The immunosuppressive properties of MSC may be detrimental in a clinical setting in which viral exposure is common. The study hypothesizes that MSC-derived IFN-gamma could offset the immune-suppressive functions of MSC and mediate partial CTL responses during viral infection. Methods. CTL responses were studied in bioassays with Cr-51-P815 targets and PBMC (uninfected or infected) as effectors. Immunofluorescence studied the relative expression of CD8(+) cells. Cytokine analyses were performed with microarrays. Roles for IFN-gamma in CTL responses were studied with IFN gamma RI mAb or with MSC knockdown for IFN-gamma by siRNA (pPMSKH1-IFN gamma). Results. MSC showed no significant effect on circulating CTL of healthy subjects. For virus-induced CTL, MSC demonstrated similar to 50% suppression. CD8(+) cell expansion could not explain the suppressive effects of MSC. Soluble factors produced by MSC were responsible for the retention of 50% CTL responses. Cytokine microarray analyses, noncontact cultures, and functional assays identified a role for IFN-gamma. MSC were identified as the relevant source of IFN-gamma. Conclusion. The results show a facilitating role of IFN-gamma on CTL responses, although paradoxical in light of the veto properties of MSC. This report shows that in cases where MSC are used in transplantation for repair of damaged tissue, they can exert an additional role by protecting the host to viral challenges and thereby protect from its immunosuppressive properties. (c) 2005 International Society for Experimental Hematology. Published by Elsevier Inc.
引用
收藏
页码:796 / 803
页数:8
相关论文
共 39 条
[1]   Management of acute graft versus host disease (GvHD) [J].
Bacigalupo, A ;
Palandri, F .
HEMATOLOGY JOURNAL, 2004, 5 (03) :189-196
[2]  
Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
[3]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[4]   Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[5]  
Bonnet Dominique, 2003, Birth Defects Research, V69, P219, DOI 10.1002/bdrc.10018
[6]   Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaques [J].
Calarota, SA ;
Otero, M ;
Hermanstayne, K ;
Lewis, M ;
Rosati, M ;
Felber, BK ;
Pavlakis, GN ;
Boyer, JD ;
Weiner, DB .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 279 (1-2) :55-67
[7]   Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals [J].
Djouad, F ;
Plence, P ;
Bony, C ;
Tropel, P ;
Apparailly, F ;
Sany, J ;
Noël, D ;
Jorgensen, C .
BLOOD, 2003, 102 (10) :3837-3844
[8]   Characterization of the expression of MHC proteins in human embryonic stem cells [J].
Drukker, M ;
Katz, G ;
Urbach, A ;
Schuldiner, M ;
Markel, G ;
Itskovitz-Eldor, J ;
Reubinoff, B ;
Mandelboim, O ;
Benvenisty, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9864-9869
[9]   Interleukin 15: biology and relevance to human disease [J].
Fehniger, TA ;
Caligiuri, MA .
BLOOD, 2001, 97 (01) :14-32
[10]  
FUKUDA K, 2003, BONE MARROW TRANSPL, V1, P25